Clinical Trials Logo

Filter by:
NCT ID: NCT03260582 Completed - Clinical trials for Myocardial Infarction

Implementation and Assessment of a Life-style Focused Patient Support Application in Myocardial Infarction Patients

Start date: April 2016
Phase: N/A
Study type: Interventional

The study will assess the efficacy of a web-based application as a complement to traditional exercise-based cardiac rehabilitation for improvement of secondary prevention outcomes in post-myocardial infarction patients, compared with usual care. The hypothesis is that the intervention enhances patient adherence to lifestyle advice (exercise training, daily physical activity, healthy diet and tobacco abstinence) and medication, resulting in better risk factor control and prognosis as well as increased self-rated health.

NCT ID: NCT03259997 Completed - Clinical trials for Physical Performance

Efficacy of Probiotics on Physical Performance

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

Efficacy of probiotics on physical performance

NCT ID: NCT03258645 Completed - Atrial Fibrillation Clinical Trials

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

Start date: November 15, 2018
Phase:
Study type: Observational

This is an observational study in patients with non-valvular atrial fibrillation (NVAF) presenting to the hospital with a first acute ischemic stroke based on existing data recorded in the SITS International Registry (located in Sweden) by physicians in several European countries, such as Italy, United Kingdom, Czech Republic, Sweden, Germany, Poland, Spain, Finland, Portugal, Slovakia, Denmark, Estonia, Norway Belgium, Hungary, Slovenia, Croatia, Austria, Lithuania, France, Greece, Netherlands, Ireland, Ukraine and Iceland. The aim of this study is to explore the current real world use of dabigatran for stroke prevention in NVAF patients in the post-stroke setting. Secondary data from eligible European patients registered in the SITS registry will be considered; countries of origin are not known a priori.

NCT ID: NCT03258268 Completed - Clinical trials for Type 2 Diabetes Mellitus

Easy Diabetes Treatment Study 1

EASY-1
Start date: August 7, 2017
Phase: N/A
Study type: Interventional

A 26-week, multicenter, parallel two-arm, randomized controlled trial of the glycemic outcomes of individualized treatment support in patients with type 2 diabetes. The primary objective of the trial is to confirm the superiority of standard of care with EASY DSS versus standard of care without EASY DSS in terms of glycemic control in patients with type 2 diabetes with ongoing treatment with any antidiabetic drug(s).

NCT ID: NCT03256604 Completed - Pneumonia Clinical Trials

A Sputum Screening Test to Rule-out Pneumonia at an Early Stage

self-test
Start date: November 2015
Phase: N/A
Study type: Observational

In patients with clinical symptoms of respiratory infection, rapid identification of cases requiring antibiotic therapy is crucial to avoid development of multiple resistant bacteria. Identification of local acute-phase reactants can help assess the host's response to bacterial infection at the injury site. Here, the investigators developed an affordable, stable, feasible, and accurate diagnostic tool based on a locally produced protein with specific binding affinity to polysaccharides. The investigators further evaluated the ability of the novel test strip to rule out pneumonia.

NCT ID: NCT03254121 Completed - Clinical trials for Hepatocellular Carcinoma

Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response

HEPCASUS
Start date: January 1, 2017
Phase:
Study type: Observational

In this international collaboration study, the research group will analyze somatic mutations of hepatocellular carcinoma (HCC) developed after sustained virological response (SVR) in patients treated with hepatitis C (HCV) therapy

NCT ID: NCT03252743 Completed - Clinical trials for Irritable Bowel Syndrome

ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.

Start date: September 1, 2017
Phase: N/A
Study type: Interventional

This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented in regular care.

NCT ID: NCT03251404 Completed - Sport Injury Clinical Trials

Effects of Injury Prevention Exercises on Performance and Neuromuscular Function

Start date: August 19, 2017
Phase: N/A
Study type: Interventional

This study evaluates the effects of two different injury prevention exercise programs on sports-relevant performance tests and neuromuscular function in youth football players. Half of participants will receive education on an existing and previously tested exercise program, while the other half will receive education on a newly developed exercise program.

NCT ID: NCT03250013 Completed - Clinical trials for Attention Deficit Disorder With Hyperactivity

Long-term Effects of Medication for ADHD

LMA
Start date: April 2014
Phase: Phase 4
Study type: Interventional

Single-centre open-label prospective study, enrolling 127 children and adolescents aged 6-17 years, who receive medication for ADHD of any subtype (presentation). Long-term results are evaluated with tests of ADHD symptoms (Qb-test), intellectual ability (Wechsler scales; WISC), adaptive functioning (Vineland scale), everyday functioning (Weiss Functional Impairment Scale; WFIRS), and quality of life (Child Health and Illness Profile-Child Edition Scale; CHIP-CE) during 24 months of ADHD treatment.

NCT ID: NCT03249688 Completed - Clinical trials for Alzheimer Disease; Prodromal

Multimodal Preventive Trial for Alzheimer's Disease

MIND-ADmini
Start date: October 16, 2017
Phase: N/A
Study type: Interventional

The main aim of the MIND-ADmini pilot trial is to evaluate the feasibility of a multimodal lifestyle intervention among patients with prodromal AD.